Neogen names Bryan Riggsbee CFO, effective November 3, 2025
Neogen Corporation appointed Bryan Riggsbee as Senior Vice President and Chief Financial Officer, effective November 3, 2025, reporting to CEO Mike Nassif. Riggsbee previously served as CFO of bioMérieux's $2 billion North American business and spent nearly a decade as CFO at Myriad Genetics. The filing sets out his pay package, including a $600,000 base salary and a $2,250,000 sign-on equity grant, which shareholders may review as a compensation commitment.
Key points
- Effective date: November 3, 2025; reports directly to CEO Mike Nassif
- Base salary $600,000; target bonus 80% of base salary; long-term incentive target $2,000,000
- Sign-on equity grant $2,250,000 plus a one-time $250,000 cash award payable by December 31, 2025
- David Naemura is expected to remain with the Company until the end of the calendar year
The filing
Written by AI on Nov 8, 2026, 6:56 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on October 30, 2025.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.